Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- PART I International Provision of Public Goods under a Globalized Intellectual Property Regime
- PART II Innovation and Technology Transfer in a Protectionist Environment
- PART III Sectoral Issues: Essential Medicines and Traditional Knowledge
- PART IV Reform and Regulation Issues
- 22 Issues Posed by a World Patent System
- 23 Intellectual Property Arbitrage: How Foreign Rules Can Affect Domestic Protections
- 24 An Agenda for Radical Intellectual Property Reform
- Comment: Whose Rules, Whose Needs? Balancing Public and Private Interests
- 25 Diffusion and Distribution: The Impacts on Poor Countries of Technological Enforcement within the Biotechnology Sector
- 26 Equitable Sharing of Benefits from Biodiversity-Based Innovation: Some Reflections under the Shadow of a Neem Tree
- 27 The Critical Role of Competition Law in Preserving Public Goods in Conflict with Intellectual Property Rights
- 28 Expansionist Intellectual Property Protection and Reductionist Competition Rules: A TRIPS Perspective
- 29 Can Antitrust Policy Protect the Global Commons from the Excesses of IPRs?
- Comment I: Competition Law as a Means of Containing Intellectual Property Rights
- 30 “Minimal” Standards for Patent-Related Antitrust Law under TRIPS
- Comment II: Competitive Baselines for Intellectual Property Systems
- 31 WTO Dispute Settlement: Of Sovereign Interests, Private Rights, and Public Goods
- 32 The Economics of International Trade Agreements and Dispute Settlement with Intellectual Property Rights
- 33 Intellectual Property Rights and Dispute Settlement in the World Trade Organization
- 34 WTO Dispute Resolution and the Preservation of the Public Domain of Science under International Law
- 35 Recognizing Public Goods in WTO Dispute Settlement: Who Participates? Who Decides? The Case of TRIPS and Pharmaceutical Patents Protection
- Index
Comment II: Competitive Baselines for Intellectual Property Systems
Published online by Cambridge University Press: 05 May 2010
- Frontmatter
- Contents
- List of contributors
- Preface
- PART I International Provision of Public Goods under a Globalized Intellectual Property Regime
- PART II Innovation and Technology Transfer in a Protectionist Environment
- PART III Sectoral Issues: Essential Medicines and Traditional Knowledge
- PART IV Reform and Regulation Issues
- 22 Issues Posed by a World Patent System
- 23 Intellectual Property Arbitrage: How Foreign Rules Can Affect Domestic Protections
- 24 An Agenda for Radical Intellectual Property Reform
- Comment: Whose Rules, Whose Needs? Balancing Public and Private Interests
- 25 Diffusion and Distribution: The Impacts on Poor Countries of Technological Enforcement within the Biotechnology Sector
- 26 Equitable Sharing of Benefits from Biodiversity-Based Innovation: Some Reflections under the Shadow of a Neem Tree
- 27 The Critical Role of Competition Law in Preserving Public Goods in Conflict with Intellectual Property Rights
- 28 Expansionist Intellectual Property Protection and Reductionist Competition Rules: A TRIPS Perspective
- 29 Can Antitrust Policy Protect the Global Commons from the Excesses of IPRs?
- Comment I: Competition Law as a Means of Containing Intellectual Property Rights
- 30 “Minimal” Standards for Patent-Related Antitrust Law under TRIPS
- Comment II: Competitive Baselines for Intellectual Property Systems
- 31 WTO Dispute Settlement: Of Sovereign Interests, Private Rights, and Public Goods
- 32 The Economics of International Trade Agreements and Dispute Settlement with Intellectual Property Rights
- 33 Intellectual Property Rights and Dispute Settlement in the World Trade Organization
- 34 WTO Dispute Resolution and the Preservation of the Public Domain of Science under International Law
- 35 Recognizing Public Goods in WTO Dispute Settlement: Who Participates? Who Decides? The Case of TRIPS and Pharmaceutical Patents Protection
- Index
Summary
Introduction
My thesis is that competitive markets, appropriately structured and regulated, are instrumental in preserving and expanding the global commons and that intellectual property systems and competition policy should work in tandem to protect the global commons. Unfortunately, the example of the developed countries, particularly the United States, is one of the failures of creating adequate and appropriate competitive baselines for intellectual property systems. Mahatma Gandhi famously quipped about Western Civilization: “It's a good idea. We should try it sometime.” Developing a more rigorous relationship between competition and intellectual property law is a good idea, worth trying. The advent of TRIPS makes this idea especially necessary.
There are two principal reasons why intellectual property law and competition law have passed each other by. The first has to do with the ambiguity in defining competition law. Under United States legal doctrine, competition law is often seen as overlapping with antitrust law, a body of legislation consisting of the Sherman Act, the Clayton Act, and the Federal Trade Commission Act. However, limiting competition policy to these bodies of law alone severely limits our understanding of the relationship between intellectual property law and competition policy and the possibilities for jurisdictions that are now developing their own legal schemes.
For example, limiting our focus to antitrust law would ignore the important role that constitutional doctrine, particularly the law of preemption, has played in balancing competition policy and intellectual property law. Preemption has historically limited the ability of intellectual property owners to extend their rights through contract.
- Type
- Chapter
- Information
- International Public Goods and Transfer of Technology Under a Globalized Intellectual Property Regime , pp. 793 - 814Publisher: Cambridge University PressPrint publication year: 2005
- 1
- Cited by